GGrantIndex
← Leaderboards

Christopher H Woelk

Veterans Medical Research Fdn/San Diego

$4,677,248
Attributed
$4,677,248
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $875.9K · FY200616
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$4,677,248 · 10

By mechanism

P30$1,493,845 · 1
R01$1,054,920 · 1
U19$1,017,554 · 1
R21$675,743 · 2
R33$393,930 · 1
M01$41,256 · 4

Top collaborators

No co-investigators on record.

Most similar at Veterans Medical Research Fdn/San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Genes

Research focus

GenesMicrornasCd4 Positive T LymphocytesResearch PersonnelInfectionGene ExpressionPathway InteractionsViralMicroarray AnalysisDesignSamplingGenomeApoptosisAntiviral AgentsResearch StudyCellsBaseTechnologyBiologyIn VitroLaboratoriesGenomicsBioinformaticsAcquired Immunodeficiency Syndrome

Grant awards (24)

Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication$393,930
R33 · FY2016 · AI · contact PI
Genomics Core$165,829
U19 · FY2015 · AI · contact PI
Genomics Core$154,390
U19 · FY2014 · AI · contact PI
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication$148,500
R21 · FY2014 · AI · contact PI
Genomics Core$229,341
U19 · FY2013 · AI · contact PI
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication$142,922
R21 · FY2013 · AI · contact PI
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication$7,190
R21 · FY2013 · AI · contact PI
Gene expression biomarkers of immune recovery in HIV infected patients$350,460
R01 · FY2012 · AI · contact PI
Genomics Core$226,779
U19 · FY2012 · AI · contact PI
Genomics$96,849
P30 · FY2012 · AI · contact PI
Gene expression biomarkers of immune recovery in HIV infected patients$350,460
R01 · FY2011 · AI · contact PI
Genomics$284,201
P30 · FY2011 · AI · contact PI
Genomics Core$241,215
U19 · FY2011 · AI · contact PI
Gene expression biomarkers of immune recovery in HIV infected patients$354,000
R01 · FY2010 · AI · contact PI
Genomics$307,987
P30 · FY2010 · AI · contact PI
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1$1,620
M01 · FY2010 · RR · contact PI
Genomics$309,448
P30 · FY2009 · AI · contact PI
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1$8,255
M01 · FY2009 · RR · contact PI
Genomics$245,009
P30 · FY2008 · AI · contact PI
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1$24,693
M01 · FY2008 · RR · contact PI
Genomics$250,351
P30 · FY2007 · AI · contact PI
Interferon Stimulated Genes with Antiviral Properties to HIV-1$134,581
R21 · FY2007 · AI · contact PI
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1$6,688
M01 · FY2007 · RR · contact PI
Interferon Stimulated Genes with Antiviral Properties to HIV-1$242,550
R21 · FY2006 · AI · contact PI